Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 27;9(1):8.
doi: 10.1186/s42234-023-00110-9.

Importance of timing optimization for closed-loop applications of vagus nerve stimulation

Affiliations
Review

Importance of timing optimization for closed-loop applications of vagus nerve stimulation

Ramanamurthy V Mylavarapu et al. Bioelectron Med. .

Abstract

In recent decades, vagus nerve stimulation (VNS) therapy has become widely used for clinical applications including epilepsy, depression, and enhancing the effects of rehabilitation. However, several questions remain regarding optimization of this therapy to maximize clinical outcomes. Although stimulation parameters such as pulse width, amplitude, and frequency are well studied, the timing of stimulation delivery both acutely (with respect to disease events) and chronically (over the timeline of a disease's progression) has generally received less attention. Leveraging such information would provide a framework for the implementation of next generation closed-loop VNS therapies. In this mini-review, we summarize a number of VNS therapies and discuss (1) general timing considerations for these applications and (2) open questions that could lead to further therapy optimization.

Keywords: Closed-loop; Stimulus Timing; Vagus Nerve Stimulation.

PubMed Disclaimer

Conflict of interest statement

JPdRV is a co-founder and managing member of InflamaCORE, LLC and has licensed patents on inflammasome proteins as biomarkers of injury and disease as well as on targeting inflammasome proteins for therapeutic purposes. JPdRV is a Scientific Advisory Board Member of ZyVersa Therapeutics.

Figures

Fig. 1
Fig. 1
Overview of VNS implementation considerations. This figure illustrates factors that can affect the development of next generation closed-loop VNS therapies. The solid arrows link general VNS implementation considerations. Disease-specific signals can be fed into algorithms on computers or other processing systems to trigger VNS. There are, however, two main considerations involved in determining the optimal timing of VNS (dotted lines): 1) the timing of stimulation with respect to a disease’s progression (A, linking the patient and affected systems) and 2) timing of stimulation with respect to recorded disease-specific events (B, linking the sensor(s) and stimulation control devices). Multiple paths and design choices can be considered for constructing a VNS system (Created, in part, via Biorender.com)

Similar articles

Cited by

References

    1. Ahmed U, et al. Strategies for precision vagus neuromodulation. Bioelectron Med. 2022;8:9. doi: 10.1186/s42234-022-00091-1. - DOI - PMC - PubMed
    1. Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bingaman WE. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure. 2006;15:491–503. doi: 10.1016/j.seizure.2006.06.002. - DOI - PubMed
    1. Anand IS, et al. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. ESC Heart Fail. 2020;7:75–83. - PMC - PubMed
    1. Bauer S, et al. Transcutaneous Vagus Nerve Stimulation (tVNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02) Brain Stimul. 2016;9:356–363. doi: 10.1016/j.brs.2015.11.003. - DOI - PubMed
    1. Bergey GK, et al. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology. 2015;84:810–817. doi: 10.1212/WNL.0000000000001280. - DOI - PMC - PubMed

LinkOut - more resources